跳至主要内容
临床试验/TCTR20210302002
TCTR20210302002已完成4 期

Efficacy of Fractional Erbium:YAG laser-assisted topical tranexamic acid delivery in facial melasma

Sasima Eimpunth, MD0 个研究点目标入组 33 人开始时间: 2021年3月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Age more than 18 years old with diagnosis of melasma by board-certified dermatologist
  • 2. Not receive any topical melasma medications within 1 month before the participation
  • 3. Not receive any laser treatments for melasma within 3 months before the participation
  • 4. Can follow the study protocol

排除标准

  • 1. Receive any topical melasma medications within 1 month before the participation
  • 2. Receive any laser treatments for melasma within 3 months before the participation
  • 3. Receive any birth control pills or hormonal injections for birth control
  • 4. Receive any estrogen or progesterone treatment
  • 5. History of allergy or any side effects related to tranexamic acid
  • 6. Any skin inflammation or sunburn on the face
  • 7. Any skin infection on the face
  • 8. Pregnancy or lactating woman
  • 9. History of keloids
  • 10. History of heart diseases, valvular heart diseases, or abnormal blood coagulation; for example; deep vein thrombosis, angina, or stroke

研究者

发起方
Sasima Eimpunth, MD

相似试验

Efficacy of fractional erbium laser-assisted... | 临床试验